Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 27241-192

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 27241-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2mg (Tolterodine 2mg)

Packaging label for Tolterodine Tartrate Extended-Release Capsules 2 mg, oral dosage form. The label indicates a bottle containing 30 capsules, marketed by Ajanta Pharma USA Inc. Storage instructions, child resistance, and a warning to keep out of reach of children are also visible. The label has a designated area marked Unvarnish OPZ 30 x 38 mm and includes the NDC 27241-191-30.*

FDA Label Image

4mg (Tolterodine 4mg)

Label for Tolterodine Tartrate Extended-Release Capsules 4 mg by Ajanta Pharma USA Inc. The label shows a package size of 30 capsules with instructions for storage and child-resistant packaging. The label also includes an NDC number 27241-192-30, barcode, and dosage information.*

FDA Label Image

Structure (Tolterodine Structure)

Chemical structure of tolterodine tartrate, showing the molecular composition with the tolterodine moiety and tartrate salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.